Drug therapy in prediabetes.

Simple item page
dc.contributor.authorMukhopadhyay, Pradipen_US
dc.contributor.authorChowdhury, Subhankaren_US
dc.date.accessioned2005-11-31en_US
dc.date.accessioned2009-05-31T09:26:28Z
dc.date.available2005-11-31en_US
dc.date.available2009-05-31T09:26:28Z
dc.date.issued2005-11-31en_US
dc.description22 references.en_US
dc.description.abstractPatients with impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) have been designated by American Diabetes Association (ADA, 2004) as having 'prediabetes', which indicates the higher risk of developing the disease in these patients. Prediabetes is important to recognise because of at least 2 major implications: increased risk for future diabetes and for atherosclerotic cardiovascular diseases. Pharmacotherapy in prediabetes should therefore be directed at preventing or, at least, delaying the onset of the disease as well as reducing the morbidity and mortality from atherosclerotic complications. Several drugs having different mechanisms of action, such as metformin, glitazones, acarbose, orlistat, nateglinide, glicazide, angiotensin-converting enzymes, angiotensin receptor blockers have been found to be effective in prediabetes to improve the glycaemic status, though they are still not recommended by any professional organisation.en_US
dc.description.affiliationDepartment of Endocrinology and Metabolism, IPGME&R, Kolkata.en_US
dc.identifier.citationMukhopadhyay P, Chowdhury S. Drug therapy in prediabetes. Journal of the Indian Medical Association. 2005 Nov; 103(11): 603-5, 608en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/98570
dc.language.isoengen_US
dc.source.urihttps://www.jimaonline.org.in/en_US
dc.subject.meshAcarbose --therapeutic useen_US
dc.subject.meshBlood Glucose --drug effectsen_US
dc.subject.meshCardiovascular Diseases --prevention & controlen_US
dc.subject.meshDiabetes Mellitus, Type 2 --drug therapyen_US
dc.subject.meshDisease Progressionen_US
dc.subject.meshHumansen_US
dc.subject.meshHyperglycemia --drug therapyen_US
dc.subject.meshHypoglycemic Agents --therapeutic useen_US
dc.subject.meshMetformin --therapeutic useen_US
dc.subject.meshPrediabetic State --drug therapyen_US
dc.subject.meshThiazolidinediones --therapeutic useen_US
dc.titleDrug therapy in prediabetes.en_US
dc.typeJournal Articleen_US
dc.typeReviewen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Indian Medical Association